Previous studies suggest that obesity-induced lymphatic damage may exacerbate metabolic abnormalities by increasing systemic and local inflammatory responses and regulating insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.